Skip to main content
NCBI home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1990 Jul;72(4):253–262.

Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

J G Williams 1
PMCID: PMC2499228  PMID: 1974406

Abstract

Phagocytic cells are prominent in the inflammatory infiltrate of Crohn's disease and ulcerative colitis. These cells secrete a variety of agents which are thought to be important in the pathogenesis of tissue damage in inflammation. The function of phagocytic cells does not appear to be impaired in inflammatory bowel disease, and certain aspects, including toxic oxygen metabolite production, are enhanced in circulating monocytes and tissue phagocytes isolated from the inflammatory site. 5-Amino-salicylic acid, used in the treatment of inflammatory bowel disease, is a specific scavenger of hypochlorite, a toxic metabolite of oxygen produced by phagocytic cells. These findings suggest that phagocytic cells play an important role in the pathogenesis of tissue damage in inflammatory bowel disease. The future development of pharmacological agents which modify specific aspects of phagocyte function, or act as scavengers of toxic oxygen metabolites produced by these cells, may provide more effective treatment for these conditions.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahnfelt-Rønne I., Nielsen O. H. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions. 1987 Jun;21(1-2):191–194. doi: 10.1007/BF01974941. [DOI] [PubMed] [Google Scholar]
  2. Ament M. E., Ochs H. D. Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med. 1973 Feb 22;288(8):382–387. doi: 10.1056/NEJM197302222880802. [DOI] [PubMed] [Google Scholar]
  3. Aruoma O. I., Wasil M., Halliwell B., Hoey B. M., Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol. 1987 Nov 1;36(21):3739–3742. doi: 10.1016/0006-2952(87)90028-1. [DOI] [PubMed] [Google Scholar]
  4. Assarsson N., Räf L. Incidence of granuloma in Crohn's disease. Acta Chir Scand. 1974;140(3):249–251. [PubMed] [Google Scholar]
  5. Azad Khan A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977 Oct 29;2(8044):892–895. doi: 10.1016/s0140-6736(77)90831-5. [DOI] [PubMed] [Google Scholar]
  6. BARON J. H., CONNELL A. M., LENNARD-JONES J. E., JONES F. A. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet. 1962 May 26;1(7239):1094–1096. doi: 10.1016/s0140-6736(62)92080-9. [DOI] [PubMed] [Google Scholar]
  7. Babior B. M., Curnutte J. T., McMurrich B. J. The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J Clin Invest. 1976 Oct;58(4):989–996. doi: 10.1172/JCI108553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Babior B. M. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med. 1978 Mar 23;298(12):659–668. doi: 10.1056/NEJM197803232981205. [DOI] [PubMed] [Google Scholar]
  9. Belsheim J., Gnarpe H., Persson S. Granulocyte chemotaxis in Crohn's disease. Acta Chir Scand. 1981;147(3):197–200. [PubMed] [Google Scholar]
  10. Berkow R. L., Wang D., Larrick J. W., Dodson R. W., Howard T. H. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol. 1987 Dec 1;139(11):3783–3791. [PubMed] [Google Scholar]
  11. Bull D. M., Bookman M. A. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest. 1977 May;59(5):966–974. doi: 10.1172/JCI108719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Campbell A. K., Hallett M. B., Weeks I. Chemiluminescence as an analytical tool in cell biology and medicine. Methods Biochem Anal. 1985;31:317–416. doi: 10.1002/9780470110522.ch7. [DOI] [PubMed] [Google Scholar]
  13. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Benatti A., Boccia S., Labo' G. Prostaglandins, indomethacin, and ulcerative colitis. Gastroenterology. 1980 Jan;78(1):193–193. [PubMed] [Google Scholar]
  14. Campieri M., Lanfranchi G. A., Bazzocehi G., Brignola C., Corazza G., Cortini C., Michelini M., Labó G. Salicylate other than 5-aminosalicylic acid ineffective in ulcerative colitis. Lancet. 1978 Nov 4;2(8097):993–993. doi: 10.1016/s0140-6736(78)92556-4. [DOI] [PubMed] [Google Scholar]
  15. Carp H., Janoff A. In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J Clin Invest. 1979 Apr;63(4):793–797. doi: 10.1172/JCI109364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clark I. A., Cowden W. B., Hunt N. H. Free radical-induced pathology. Med Res Rev. 1985 Jul-Sep;5(3):297–332. doi: 10.1002/med.2610050303. [DOI] [PubMed] [Google Scholar]
  17. Clark R. A., Klebanoff S. J. Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. J Exp Med. 1975 Jun 1;141(6):1442–1447. doi: 10.1084/jem.141.6.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Curnutte J. T., Whitten D. M., Babior B. M. Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med. 1974 Mar 14;290(11):593–597. doi: 10.1056/NEJM197403142901104. [DOI] [PubMed] [Google Scholar]
  19. DICK A. P., GRAYSON M. J., CARPENTER R. G., PETRIE A. CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS. Gut. 1964 Oct;5:437–442. doi: 10.1136/gut.5.5.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. DUKES C. E. The surgical pathology of ulcerative colitis. Ann R Coll Surg Engl. 1954 Jun;14(6):389–400. [PMC free article] [PubMed] [Google Scholar]
  21. DeChatelet L. R., Long G. D., Shirley P. S., Bass D. A., Thomas M. J., Henderson F. W., Cohen M. S. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol. 1982 Oct;129(4):1589–1593. [PubMed] [Google Scholar]
  22. Del Maestro R., Thaw H. H., Björk J., Planker M., Arfors K. E. Free radicals as mediators of tissue injury. Acta Physiol Scand Suppl. 1980;492:43–57. [PubMed] [Google Scholar]
  23. Dew M. J., Hughes P. J., Lee M. G., Evans B. K., Rhodes J. An oral preparation to release drugs in the human colon. Br J Clin Pharmacol. 1982 Sep;14(3):405–408. doi: 10.1111/j.1365-2125.1982.tb01999.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dewald B., Baggiolini M., Curnutte J. T., Babior B. M. Subcellular localization of the superoxide-forming enzyme in human neutrophils. J Clin Invest. 1979 Jan;63(1):21–29. doi: 10.1172/JCI109273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Dull B. J., Salata K., Van Langenhove A., Goldman P. 5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage. Biochem Pharmacol. 1987 Aug 1;36(15):2467–2472. doi: 10.1016/0006-2952(87)90518-1. [DOI] [PubMed] [Google Scholar]
  26. Elmgreen J., Binder V. The chemotactic function of neutrophils in ulcerative colitis. Scand J Gastroenterol. 1982 Jun;17(4):561–564. doi: 10.3109/00365528209182250. [DOI] [PubMed] [Google Scholar]
  27. Faden H., Rossi T. M. Chemiluminescent response of neutrophils from patients with inflammatory bowel disease. Dig Dis Sci. 1985 Feb;30(2):139–142. doi: 10.1007/BF01308200. [DOI] [PubMed] [Google Scholar]
  28. Fantone J. C., Ward P. A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982 Jun;107(3):395–418. [PMC free article] [PubMed] [Google Scholar]
  29. Fridovich I. Editorial: Superoxide radical and the bactericidal action of phagocytes. N Engl J Med. 1974 Mar 14;290(11):624–625. doi: 10.1056/NEJM197403142901112. [DOI] [PubMed] [Google Scholar]
  30. Ganguly N. K., Kingham J. G., Lloyd B., Lloyd R. S., Price C. P., Triger D. R., Wright R. Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet. 1978 May 20;1(8073):1073–1075. doi: 10.1016/s0140-6736(78)90917-0. [DOI] [PubMed] [Google Scholar]
  31. Gorbach S. L., Nahas L., Plaut A. G., Weinstein L., Patterson J. F., Levitan R. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology. 1968 Apr;54(4):575–587. [PubMed] [Google Scholar]
  32. Greenwald R. A., Moy W. W. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980 Apr;23(4):455–463. doi: 10.1002/art.1780230408. [DOI] [PubMed] [Google Scholar]
  33. Hallett M. B., Campbell A. K. Two distinct mechanisms for stimulation of oxygen-radical production by polymorphonuclear leucocytes. Biochem J. 1983 Nov 15;216(2):459–465. doi: 10.1042/bj2160459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Halliwell B., Gutteridge J. M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984 Apr 1;219(1):1–14. doi: 10.1042/bj2190001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Harris D. W., Swan C. H. Increased synthesis of prostaglandins in ulcerative colitis. Lancet. 1977 Jul 23;2(8030):196–196. doi: 10.1016/s0140-6736(77)90215-x. [DOI] [PubMed] [Google Scholar]
  36. Holmes B., Page A. R., Good R. A. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest. 1967 Sep;46(9):1422–1432. doi: 10.1172/JCI105634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Isaacs D., Wright V. M., Shaw D. G., Raafat F., Walker-Smith J. A. Chronic granulomatous disease mimicking Crohn's disease. J Pediatr Gastroenterol Nutr. 1985 Jun;4(3):498–501. doi: 10.1097/00005176-198506000-00030. [DOI] [PubMed] [Google Scholar]
  38. Janoff A., Carp H. Proteases, antiproteases, and oxidants: pathways of tissue injury during inflammation. Monogr Pathol. 1982;(23):62–82. [PubMed] [Google Scholar]
  39. Johnson K. J., Fantone J. C., 3rd, Kaplan J., Ward P. A. In vivo damage of rat lungs by oxygen metabolites. J Clin Invest. 1981 Apr;67(4):983–993. doi: 10.1172/JCI110149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Johnson K. J., Varani J., Oliver J., Ward P. A. Immunologic vasculitis in beige mice with deficiency of leukocytic neutral protease. J Immunol. 1979 May;122(5):1807–1811. [PubMed] [Google Scholar]
  41. Kellogg E. W., 3rd, Fridovich I. Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide. J Biol Chem. 1977 Oct 10;252(19):6721–6728. [PubMed] [Google Scholar]
  42. Kirk A. P., Cason J., Fordham J. N., Brown K. A., Goddard D. H., Holborow E. J., Lennard-Jones J. E. Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease. Dig Dis Sci. 1983 Mar;28(3):236–248. doi: 10.1007/BF01295119. [DOI] [PubMed] [Google Scholar]
  43. Klebanoff S. J., Vadas M. A., Harlan J. M., Sparks L. H., Gamble J. R., Agosti J. M., Waltersdorph A. M. Stimulation of neutrophils by tumor necrosis factor. J Immunol. 1986 Jun 1;136(11):4220–4225. [PubMed] [Google Scholar]
  44. Korelitz B. I., Sommers S. C. Differential diagnosis of ulcerative and granulomatous colitis by sigmoidoscopy, rectal biopsy and cell counts of rectal mucosa. Am J Gastroenterol. 1974 Jun;61(6):460–469. [PubMed] [Google Scholar]
  45. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Mahida Y. R., Patel S., Gionchetti P., Vaux D., Jewell D. P. Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut. 1989 Jun;30(6):826–834. doi: 10.1136/gut.30.6.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Matheson N. R., Wong P. S., Travis J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun. 1979 May 28;88(2):402–409. doi: 10.1016/0006-291x(79)92062-x. [DOI] [PubMed] [Google Scholar]
  48. McCord J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974 Aug 9;185(4150):529–531. doi: 10.1126/science.185.4150.529. [DOI] [PubMed] [Google Scholar]
  49. Mee A. S., Szawatakowski M., Jewell D. P. Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing. J Clin Pathol. 1980 Oct;33(10):921–925. doi: 10.1136/jcp.33.10.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Miyachi Y., Imamura S., Niwa Y. Erythema multiforme: a possible pathogenetic role of increased reactive oxygen species. J Clin Lab Immunol. 1986 Jan;19(1):11–14. [PubMed] [Google Scholar]
  51. Miyachi Y., Yoshioka A., Imamura S., Niwa Y. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut. 1987 Feb;28(2):190–195. doi: 10.1136/gut.28.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Molin L., Stendahl O. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis. Acta Med Scand. 1979;206(6):451–457. doi: 10.1111/j.0954-6820.1979.tb13545.x. [DOI] [PubMed] [Google Scholar]
  53. Moráin C. O., Segal A. A., Walker D., Levi A. J. Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut. 1981 Oct;22(10):817–822. doi: 10.1136/gut.22.10.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Nathan C. F., Murray H. W., Cohn Z. A. The macrophage as an effector cell. N Engl J Med. 1980 Sep 11;303(11):622–626. doi: 10.1056/NEJM198009113031106. [DOI] [PubMed] [Google Scholar]
  55. Neal T. M., Vissers M. C., Winterbourn C. C. Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol. 1987 Aug 1;36(15):2511–2517. doi: 10.1016/0006-2952(87)90524-7. [DOI] [PubMed] [Google Scholar]
  56. Neal T. M., Winterbourn C. C., Vissers M. C. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine. Biochem Pharmacol. 1987 Sep 1;36(17):2765–2768. doi: 10.1016/0006-2952(87)90262-0. [DOI] [PubMed] [Google Scholar]
  57. Niwa Y., Miyake S., Sakane T., Shingu M., Yokoyama M. Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol. 1982 Jul;49(1):247–255. [PMC free article] [PubMed] [Google Scholar]
  58. Okabe N., Kuroiwa A., Fujita K., Shibuya T., Yao T., Okumura M. Immunological studies on Crohn's disease. VI. Increased chemiluminescent response of peripheral blood monocytes. J Clin Lab Immunol. 1986 Sep;21(1):11–15. [PubMed] [Google Scholar]
  59. Olsson I., Venge P. The role of the human neutrophil in the inflammatory reaction. Allergy. 1980 Jan;35(1):1–13. doi: 10.1111/j.1398-9995.1980.tb01711.x. [DOI] [PubMed] [Google Scholar]
  60. Peppercorn M. A., Goldman P. Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology. 1973 Feb;64(2):240–245. [PubMed] [Google Scholar]
  61. Petrone W. F., English D. K., Wong K., McCord J. M. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci U S A. 1980 Feb;77(2):1159–1163. doi: 10.1073/pnas.77.2.1159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Rampton D. S., Sladen G. E. Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment. Prostaglandins. 1981 Mar;21(3):417–425. doi: 10.1016/0090-6980(81)90087-3. [DOI] [PubMed] [Google Scholar]
  64. Rhodes J. M., Bartholomew T. C., Jewell D. P. Inhibition of leucocyte motility by drugs used in ulcerative colitis. Gut. 1981 Aug;22(8):642–647. doi: 10.1136/gut.22.8.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Rhodes J. M., Jewell D. P. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis. Gut. 1983 Jan;24(1):73–77. doi: 10.1136/gut.24.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sachar D. B., Auslander M. O., Walfish J. S. Aetiological theories of inflammatory bowel disease. Clin Gastroenterol. 1980 May;9(2):231–257. [PubMed] [Google Scholar]
  67. Schmidt M. E., Douglas S. D. Monocyte IgG receptor activity, dynamics, and modulation-normal individuals and patients with granulomatous diseases. J Lab Clin Med. 1977 Feb;89(2):332–340. [PubMed] [Google Scholar]
  68. Schröder H., Campbell D. E. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther. 1972 Jul-Aug;13(4):539–551. doi: 10.1002/cpt1972134539. [DOI] [PubMed] [Google Scholar]
  69. Selby W. S., Poulter L. W., Hobbs S., Jewell D. P., Janossy G. Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol. 1983 Apr;36(4):379–384. doi: 10.1136/jcp.36.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  71. Sharon P., Ligumsky M., Rachmilewitz D., Zor U. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology. 1978 Oct;75(4):638–640. [PubMed] [Google Scholar]
  72. Smith P. R., Dawson D. J., Swan C. H. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone. Gut. 1979 Sep;20(9):802–805. doi: 10.1136/gut.20.9.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sommers S. C., Korelitz B. I. Mucosal-cell counts in ulcerative and granulomatous colitis. Am J Clin Pathol. 1975 Mar;63(3):359–365. doi: 10.1093/ajcp/63.3.359. [DOI] [PubMed] [Google Scholar]
  74. Spectro W. G. The cellular dynamics of granulomas. Proc R Soc Med. 1971 Sep;64(9):941–942. doi: 10.1177/003591577106400928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Summers R. W., Switz D. M., Sessions J. T., Jr, Becktel J. M., Best W. R., Kern F., Jr, Singleton J. W. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 Oct;77(4 Pt 2):847–869. [PubMed] [Google Scholar]
  76. Sutton J. S., Weiss L. Transformation of monocytes in tissue culture into macrophages, epithelioid cells, and multinucleated giant cells. An electron microscope study. J Cell Biol. 1966 Feb;28(2):303–332. doi: 10.1083/jcb.28.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Tanner A. R., Arthur M. J., Wright R. Macrophage activation, chronic inflammation and gastrointestinal disease. Gut. 1984 Jul;25(7):760–783. doi: 10.1136/gut.25.7.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Verspaget H. W., Elmgreen J., Weterman I. T., Peña A. S., Riis P., Lamers C. B. Impaired activation of the neutrophil oxidative metabolism in chronic inflammatory bowel disease. Scand J Gastroenterol. 1986 Nov;21(9):1124–1130. doi: 10.3109/00365528608996432. [DOI] [PubMed] [Google Scholar]
  79. Verspaget H. W., Mieremet-Ooms M. A., Weterman I. T., Peña A. S. Partial defect of neutrophil oxidative metabolism in Crohn's disease. Gut. 1984 Aug;25(8):849–853. doi: 10.1136/gut.25.8.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Verspaget H., Beeken W. Mononuclear phagocytes in the gastrointestinal tract. Acta Chir Scand Suppl. 1985;525:113–126. [PubMed] [Google Scholar]
  81. WARREN S., SOMMERS S. C. Cicatrizing enteritis as a pathologic entity; analysis of 120 cases. Am J Pathol. 1948 May;24(3):475–501. [PMC free article] [PubMed] [Google Scholar]
  82. Ward M. The pathogenesis of Crohn's disease. Lancet. 1977 Oct 29;2(8044):903–905. doi: 10.1016/s0140-6736(77)90835-2. [DOI] [PubMed] [Google Scholar]
  83. Ward P. A. Neutrophil chemotactic factors and related clinical disorders. Arthritis Rheum. 1970 Mar-Apr;13(2):181–186. doi: 10.1002/art.1780130210. [DOI] [PubMed] [Google Scholar]
  84. Weiss S. J., Lampert M. B., Test S. T. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science. 1983 Nov 11;222(4624):625–628. doi: 10.1126/science.6635660. [DOI] [PubMed] [Google Scholar]
  85. Weiss S. J., LoBuglio A. F. An oxygen-dependent mechanism of neutrophil-mediated cytotoxicity. Blood. 1980 Jun;55(6):1020–1024. [PubMed] [Google Scholar]
  86. Weiss S. J. Oxygen, ischemia and inflammation. Acta Physiol Scand Suppl. 1986;548:9–37. [PubMed] [Google Scholar]
  87. Weiss S. J., Peppin G., Ortiz X., Ragsdale C., Test S. T. Oxidative autoactivation of latent collagenase by human neutrophils. Science. 1985 Feb 15;227(4688):747–749. doi: 10.1126/science.2982211. [DOI] [PubMed] [Google Scholar]
  88. Weiss S. J., Young J., LoBuglio A. F., Slivka A., Nimeh N. F. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest. 1981 Sep;68(3):714–721. doi: 10.1172/JCI110307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Whorwell P. J., Bennett P., Tanner A. R., Wright R. Monocyte function in Crohn's disease and ulcerative colitis. Digestion. 1981;22(5):271–275. doi: 10.1159/000198668. [DOI] [PubMed] [Google Scholar]
  90. Williams J. G., Hallett M. B. Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils. Gut. 1989 Nov;30(11):1581–1587. doi: 10.1136/gut.30.11.1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Williams J. G., Hallett M. B. The reaction of 5-amino-salicylic acid with hypochlorite. Implications for its mode of action in inflammatory bowel disease. Biochem Pharmacol. 1989 Jan 1;38(1):149–154. doi: 10.1016/0006-2952(89)90161-5. [DOI] [PubMed] [Google Scholar]
  92. Williams J. G., Hughes L. E., Hallett M. B. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut. 1990 Feb;31(2):187–193. doi: 10.1136/gut.31.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Winter H. S., Cole F. S., Huffer L. M., Davidson C. B., Katz A. J., Edelson P. J. Isolation and characterization of resident macrophages from guinea pig and human intestine. Gastroenterology. 1983 Aug;85(2):358–363. [PubMed] [Google Scholar]
  94. Worsaae N., Staehr Johansen K., Christensen K. C. Impaired in vitro function of neutrophils in Crohn's disease. Scand J Gastroenterol. 1982 Jan;17(1):91–96. doi: 10.3109/00365528209181050. [DOI] [PubMed] [Google Scholar]
  95. ZUCKER-FRANKLIN D., HIRSCH J. G. ELECTRON MICROSCOPE STUDIES ON THE DEGRANULATION OF RABBIT PERITONEAL LEUKOCYTES DURING PHAGOCYTOSIS. J Exp Med. 1964 Oct 1;120:569–576. doi: 10.1084/jem.120.4.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. van Hees P. A., Bakker J. H., van Tongeren J. H. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. Gut. 1980 Jul;21(7):632–635. doi: 10.1136/gut.21.7.632. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES